These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Posterior juxtascleral depot administration of anecortave acetate. Kaiser PK; Goldberg MF; Davis AA; Surv Ophthalmol; 2007 Jan; 52 Suppl 1():S62-9. PubMed ID: 17240258 [TBL] [Abstract][Full Text] [Related]
9. [Present status of studies on the treatment of choroidal neovascularization by Anecortave acetate]. Li X; Wang YS Zhonghua Yan Ke Za Zhi; 2008 Jun; 44(6):571-4. PubMed ID: 19035252 [TBL] [Abstract][Full Text] [Related]
10. Anecortave acetate treatment for retinal angiomatous proliferation: a pilot study. Klais CM; Eandi CM; Ober MD; Sorenson JA; Sadeghi SN; Freund KB; Spaide RF; Slakter JS; Yannuzzi LA Retina; 2006 Sep; 26(7):773-9. PubMed ID: 16963850 [TBL] [Abstract][Full Text] [Related]
11. Mechanism of action of the angiostatic cortisene anecortave acetate. Clark AF Surv Ophthalmol; 2007 Jan; 52 Suppl 1():S26-34. PubMed ID: 17240253 [TBL] [Abstract][Full Text] [Related]
12. The effect of an angiostatic steroid on neovascularization in a rat model of retinopathy of prematurity. Penn JS; Rajaratnam VS; Collier RJ; Clark AF Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):283-90. PubMed ID: 11133880 [TBL] [Abstract][Full Text] [Related]